Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy.

CONCLUSION: Most patients treated with PT for LA-NSCLC have unfavorable risk factors. These patients had similar outcomes to favorable-risk patients. Enrollment in future clinical trials may improve if eligibility is less restrictive.
PMID: 30656994 [PubMed - as supplied by publisher]

Source: Acta Oncologica - January 18, 2019 Category: Cancer & Oncology Authors: Zhu HJ, Nichols RC, Henderson RH, Morris CG, Flampouri S, Pham DC, Klassen CL, Seeram V, Cury JD, Jones L, McGee L, Hoppe BS Tags: Acta Oncol Source Type: research